Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients.

The pharmacokinetics of thalidomide in nine human immunodeficiency virus-infected patients were studied. Single doses of thalidomide were well absorbed, with mean peak concentrations (+/- standard deviations) of 1.17 +/- 0.21 and 3.47 +/- 1.14 microg/ml in the 100- and 300-mg dosing groups, respecti...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Piscitelli, S C, Figg, W D, Hahn, B, Kelly, G, Thomas, S, Walker, R E
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164214/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9420064/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.12.2797
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!